 | SCYNEXIS Inc (SCYX) Short Interest Up 27.7% in January
www.americanbankingnews.com - February 13 at 4:06 AM |
 | Scynexis: A Novel Antifungal Drug Against Life-Threatening Resistant Infections And Ridiculously Cheap Valuation - Seeking Alpha
seekingalpha.com - February 11 at 8:26 AM |
| SCYNEXIS Inc (SCYX) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - February 4 at 1:34 AM |
 | SCYNEXIS Inc.
www.barrons.com - February 1 at 8:20 AM |
 | AVITA Turns Heads, SENS' Eversense Is "MRI Safe", SCYX Jumps 100% On FURI Data - Nasdaq
www.nasdaq.com - January 31 at 6:36 PM |
| U.S. STOCKS ON THE MOVE-Facebook, GE, DowDuPont, UPS, Intel, Scynexis - Nasdaq
www.nasdaq.com - January 31 at 6:36 PM |
| U.S. STOCKS ON THE MOVE-GE, Tesla, Facebook, DowDuPont, UPS - Nasdaq
www.nasdaq.com - January 31 at 6:36 PM |
| SCYNEXIS up 26% after hours on positive ibrexafungerp data
seekingalpha.com - January 30 at 7:07 PM |
 | SCYNEXIS Announces Positive Interim Results from Phase 3 Open-Label FURI Study, Showing Oral Ibrexafungerp's Ability to Treat Refractory Fungal Infections and to Provide an Alternative to Long-Term IV Therapies
finance.yahoo.com - January 30 at 7:07 PM |
 | Form 3 SCYNEXIS INC For: Jan 21 Filed by: ANIDO ARMANDO - StreetInsider.com
www.streetinsider.com - January 25 at 6:15 PM |
| Does SCYNEXIS, Inc.’s (NASDAQ:SCYX) CEO Salary Reflect Performance?
finance.yahoo.com - January 21 at 6:02 PM |
| Tuesday 1/15 Insider Buying Report: SCYX
www.nasdaq.com - January 15 at 6:11 PM |
 | SCYNEXIS Provides Year-end Update and Outlines Plans for 2019 - PRNewswire
www.prnewswire.com - January 5 at 8:14 AM |
| SCYNEXIS, Inc.
www.streetinsider.com - November 14 at 8:13 AM |
| SCYNEXIS beats by $0.15, misses on revenue
seekingalpha.com - November 13 at 5:14 PM |
| Scynexis: 3Q Earnings Snapshot
finance.yahoo.com - November 13 at 5:14 PM |
| SCYNEXIS Reports Third Quarter 2018 Financial Results and Provides Company Update
finance.yahoo.com - November 13 at 5:14 PM |
| Scynexis (SCYX) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 13 at 5:14 PM |
 | Will Scynexis (SCYX) Report Negative Earnings Next Week? What You Should Know
www.zacks.com - October 31 at 8:15 AM |
| SCYNEXIS Announces FDA Agreement with Company-Proposed Phase 3 Vulvovaginal Candidiasis Program for Oral Ibrexafungerp
finance.yahoo.com - October 23 at 5:08 PM |
| SCYNEXIS, Inc. Announces First Patient Dosed in Phase 3 Open-label Study Evaluating Oral Ibrexafungerp in Candida ...
www.prnewswire.com - October 17 at 5:01 PM |
| SCYNEXIS, Inc. Announces First Patient Dosed in Phase 3 Open-label Study Evaluating Oral Ibrexafungerp in Candida auris Infections (CARES)
finance.yahoo.com - October 15 at 5:09 PM |
| SCYNEXIS Supports AMR Challenge and Fungal Disease Awareness Week
finance.yahoo.com - October 1 at 4:59 PM |
| SCYNEXIS to Present an Overview of the Company's Pipeline at IDWeek 2018
finance.yahoo.com - September 26 at 8:20 AM |
| SCYNEXIS, Inc. to Present at Upcoming Investor Conferences
finance.yahoo.com - September 25 at 8:12 AM |
| Who Owns SCYNEXIS Inc (NASDAQ:SCYX)?
finance.yahoo.com - September 18 at 5:01 PM |
| SCYNEXIS, Inc. to Participate in Upcoming Investor Conferences
finance.yahoo.com - August 29 at 8:23 AM |
| SCYNEXIS misses by $0.06, misses on revenue
seekingalpha.com - August 10 at 8:15 AM |
| Scynexis (SCYX) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 10 at 8:15 AM |
| Scynexis: 2Q Earnings Snapshot
finance.yahoo.com - August 9 at 6:08 PM |
| SCYNEXIS Reports Second Quarter 2018 Financial Results and Provides Company Update
finance.yahoo.com - August 9 at 6:08 PM |
| The World Health Organization Recognizes New Antifungal Class by Granting "ibrexafungerp" to SCYNEXIS as the International Non-Proprietary Name for SCY-078
finance.yahoo.com - July 18 at 4:53 PM |
| Week Ahead In Pharmaceuticals - 7 Stocks To Watch
www.nasdaq.com - July 14 at 3:39 PM |
| SCYNEXIS: An Update On This ~$2 'Lottery Ticket'
seekingalpha.com - July 14 at 3:39 PM |
| Why Scynexis Stock Rose 16.4% Yesterday
finance.yahoo.com - July 12 at 4:49 PM |
| Biotech Analysis Central Pharma News: Pfizer's Unit Separation, BioCryst's Merger Collapses, Scynexis' Positive Mid-Stage Results
seekingalpha.com - July 12 at 8:15 AM |
| SCYNEXIS selects dose regimen for late-stage studies of antifungal SCY-078
seekingalpha.com - July 11 at 8:12 AM |
| Scynexis (SCYX) Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in VVC
www.streetinsider.com - July 10 at 5:00 PM |
| SCYNEXIS Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in Vulvovaginal Candidiasis
finance.yahoo.com - July 10 at 5:00 PM |
| Complimentary Technical Snapshots on Mylan and Three More Generic Drugs Stocks
finance.yahoo.com - July 2 at 8:23 AM |
| SCYNEXIS Announces the Presentation of SCY-078 Data at the Teratology Society 58th Annual Meeting
finance.yahoo.com - June 27 at 8:48 AM |
| Scynexis, Undervalued And Filling A Critical Need In The Antifungal Space
seekingalpha.com - June 26 at 5:20 PM |
| Form 8-K SCYNEXIS INC For: Jun 14
www.streetinsider.com - June 22 at 5:45 PM |
| SCYNEXIS to Present SCY-078 Data at Three Scientific Meetings in June/July 2018
finance.yahoo.com - June 14 at 8:18 AM |
| SCYNEXIS Presents SCY-078 Data at ASM Microbe 2018
finance.yahoo.com - June 11 at 5:14 PM |
| Your Daily Pharma Scoop: Scynexis Moves Up, Proteostasis Disappoints Investors, Cellectar Zooms
seekingalpha.com - June 11 at 8:12 AM |
| SCYNEXIS announces publication of early-stage SCY-078 data; shares up 2% premarket
seekingalpha.com - June 6 at 5:31 PM |
| SCYNEXIS to Present SCY-078 Data at ASM Microbe 2018
finance.yahoo.com - May 24 at 5:46 PM |
| Free Daily Technical Summary Reports on Mylan and Three Other Generic Drugs Stocks
finance.yahoo.com - May 24 at 8:15 AM |
| SCYNEXIS to Participate in a Panel at the 2018 BIO International Convention
finance.yahoo.com - May 23 at 5:40 PM |
